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MODERN METHODS IN THE HISTORY OF MEDICINE. Edited by Edwin Clarke.
Athlone Press of the University of London, 1971. 389 pp.
New approaches are explored for historians, by 19 eminent writers, in 21 chap-
ters of timely information. The historiography of ideas in medicine, as one aspect,
notes that the historian of science is concerned with the thoughts that refer to facts
and theories, be they true or not; whereas the scientist is concerned with facts
and theories, asking whether they are true or not.
Most of the methods and techniques described have been introduced into the
history of medicine recently. The investigation of disease, the rise of automation,
statistical methods, diagrams, maps, oral history, practical history, and copying ma-
chines are considered. Aims to complement and supplement more traditional meth-
ods are discussed, besides possible directions as an academic discipline. Enhanced
accuracy and the production of good history, while assisting in creating a more
precise form, are objectives. Clarity of expression in this carefully assembled vol-
ume is only one of its virtues, besides valuable notes and references and a useful
index.
IRA VAUGHAN HISCOCK
Professor Emeritus of Public Health
Yale University School of Medicine
THE BIOLOGY OF ONCOGENIC VIRUSES. Edited by L. G. Silvestri. American
Elsevier Publishing Company, Inc., New York, 1971. xii, 339 pp. $14.25
(Paperbound).
The prominent avenues of research in oncogenic virology are outlined in the
collected papers which comprise this book. In attempting to discover what controls
the expression of viral information in transformed cells, the small DNA viruses,
polyoma and SV40 are the major research tools. The picture which emerges at
present is that the entire viral DNA genome is integrated into the cell chromosome,
that only part of the genome is transcribed as viral-specific RNA (so-called "early"
functions), and that the transcribed viral RNA is found as large pieces perhaps
containing some cellular transcripts in the cell nucleus and smaller pieces in the
cytoplasm. It would be desirable to use viral DNA to make viral proteins in vitro,
and a group at Cold Spring Harbor have started in this direction. SV40 DNA has
been used as a template in a protein-synthesizing system and, although the product
does not correspond to the capsid protein of SV40, new proteins are apparently
made. Another problem which has occupied workers concerned with the biology
of RNA tumor viruses, is that the Rous sarcoma virus (RSV) is capable of trans-
forming cells, but not of replicating into complete virus without a "helper" virus.
One strain of RSV, which appeared to be independent of "helper" virus, has now
been shown by several groups to require a helper genetic material indigenous to
certain chick cells. Another exciting observation is that strains of avian tumor
viruses capable of transforming cells in vitro possess a subunit of RNA which is
absent from avian tumor viruses (such as the leukosis group) which do not trans-
form in vitro.
Characteristics of the RNA to DNA polymerase (reverse transcriptase) are de-
scribed in several papers, and Temin discusses the implications of this enzyme forBOOK REVIEWS 157
the mechanism of transformation by RNA viruses. Benyesh-Melnick and co-work-
ers describe the presence of DNA in purified murine leukemia-sarcoma virus prepa-
rations, suggesting that, in addition to unexpectedly complex enzymatic machinery,
some tumor viruses may contain more than one type of nucleic acid.
Several groups analyze differences in the membranes of transformed and normal
cells. Burger, for example, has shown that receptor sites for wheat germ agglutinins
appear on transformed cells. Another trend of research is to obtain conditional
lethal mutants of tumor viruses with the ultimate aim of defining which viral genes
are responsible for cell transformation.
The volume is admirable because it presents contemporary research about
oncogenic transformation at the cellular and molecular levels with only a brief
interval between the meeting and publication of its papers. The manuscripts are
reproduced directly with a minimum of editing. A more finished product would
have certainly included some collation and interpretation of the research trends.
Many of the manuscripts have extensive bibliographies so the book should serve
as an excellent introduction to the literature of the oncogenic viruses.
What of the impact of this research to the "cancer problem"? The focus of this
volume is almost entirely on the oncogenic virus per se. Very little is said of the
genetic and phenotypic changes in the cell which modulate the influence of the
tumor virus; the response of host to the viral-transformed cell is not mentioned.
J. GEORGE MILLER
Department of Pediatrics
Yale University School of Medicine
HORMONAL CONTRACEPTION. By Jurgen Haller. Geron-X, Inc., Los Altos, Calif.,
1972. 314 PP. $13.00.
This book is a translation from the third German edition, published in 1971.
PerhaLps the rendering of this volume into English is responsible for some of its
problems, but I don't think so. The book is poorly organized and written in an
oversimplified, fragmentary form. Furthermore, American readers would be con-
fused by the use of European trade names and techniques. Indeed there is little
to recommend.
Besides objecting to the style of the book, one can also criticize the author for
itiaccuracies. For example, function of the corpus luteum is attributed to a luteo-
trophic hormone (LTH). LTH in the primate is prolactin, an anterior pituitary
hormone which is not essential for development and maintenance of the corpus
luteuLm. Increased intraovular pressure is assigned a key role in ovulation, despite
evidence to the contrary. Typographical errors contribute to the inadequacies of
this book.
A severe deficiency is the almost total disregard for data arising from radioim-
munoassay assessment of gonadal and pituitary hormone levels. Instead a great
deal of space is devoted to outdated bioassay and urinary biochemical methods.
Finally, the author champions several questionable entities. Uterine hypoplasia
is accepted as a cause of infertility, treatable with cyclic hormone administration.
Uterine hypoplasia has not been encountered in the Yale Infertility Clinic. A chap-
ter is devoted to a rebound phenomenon (spontaneous ovulation) following treat-